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Objectives: To evaluate the efficacy of the addition of plaque ablation by hot-tip laser to balloon angioplasty. 
Design: Prospective randomised clinical trial. 
Materials and methods: Patients with either occlusion or > 50% diameter stenosis less than 3cm in length in the 
superficial femoral artery, and with two or three calf vessel run-off were eligible and randomised to receive ither balloon 
angioplasty alone or with laser assistance. Treatment failure in follow-up was defined as reocclusion or recurrence of greater 
than 50% stenosis at the site of angioplasty. 
Results: Ninety limbs (82 patients) were entered into the study. Forty-four patients had mild claudication, 32 more severe 
symptoms and 6 rest pain or ulceration. More patients with diabetes (5 of 5, p = 0.04, Fisher 's exact est) and occlusions 
(16 of 22, p < 0.05, X 2) were randomised to the laser group. Initial technical success was obtained in all lesions. The median 
duration of follow-up was 1 year. 
Failure occurred in 40 limbs during follow-up. Three segments, all with initial occlusions and undergoing laser angioptasty 
re-occluded within 2 days, one requiring immediate thrombectomy. Another 20 limbs underwent further intervention. 
Overall success ( + s.m.) (Kaplan-Meier) at 1 year was 67% ( + 5%) and at 2 years 43% ( +_ 7%). Only increased age, initial 
occlusion, female sex, and not smoking were significantly (p < 0.05, Cox's proportional hazards) associated with failure; on 
multivariate analysis, age and occlusion were the best independent predictors. There was no significant difference (p > 0.05) 
in outcome between limbs undergoing laser assisted balloon angioplasty and balloon alone either overall or within the 
stenosis or occlusion subgroups. 
Conclusions: This study found no significant benefit was gained by the addition of laser to balloon angioplasty and that 
the long term success was modest for lesions considered to be suitable for angioplasty. 
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Introduction 
Percutaneous balloon angioplasty has become a pop- 
ular technique for treating localised arterial disease 
but is limited by the development of restenosis. It has 
been proposed that debulking of plaque in combina- 
tion with balloon angioplasty will result in higher 
primary patency and lower restenosis rates. 1 Laser 
vaporisation of plaque, performed prior to conven- 
tional balloon angioplast~ theoretically provides uch 
debulking of atheroma s well as preventing distal 
propagation of debris. Laser techniques, expensive 
both in hardware and disposables, have been intro- 
duced with much enthusiasm, but also readily aban- 
doned with few controlled scientific studies. A pro- 
*Please address all correspondence to: J. P. Fletcher, Department of 
Surger~ Westmead Hospital Westmead 2145, Sydne~ Australia. 
spective randomised clinical trial to evaluate the 
efficacy of laser assisted balloon angioplasty com- 
pared to conventional balloon angioplasty alone in the 
treatment of localised disease in the superficial 
femoral artery was performed. 
Methods 
Entry criteria and randomisation 
Patients with isolated occlusions less than 3cm in 
length or stenoses greater than 50% in the superficial 
femoral artery, and with popliteal and two or three 
calf vessel run-off were eligible for entry. Patients with 
iliac or popliteal artery occlusion or significant sten- 
osis were specifically excluded. Patient related data 
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including age, sex, diabetes, ischaemic heart disease 
and hypertension were recorded. Patients underwent 
resting and exercise ankle brachial indices (ABPI), 
Duplex scanning and angiography prior to entry into 
the study. The type of lesion and run-off were 
confirmed by angiography prior to randomisation to
receive either balloon angioplasty using standard 
techniques or balloon angioplasty following laser. 
Procedures were performed at three University 
teaching hospitals either by an interventional radi- 
ologist in the angiography suite or in the operating 
suite by a vascular surgeon experienced in endovas- 
cular techniques. A Trimedyne Argon or Nd:YAG 
"over the wire hot tip" laser system was used for 
patients allocated to the laser group. 2'3 
Table 1. Univariate Cox proportional hazards analysis 
Number Co- Odds 
Factor of limbs efficient S.D. p ratio 95% CI  
Age(years) 90 0.06 0.02 0.005 1.06 1.02 1.11 
Non-smoker 24 0.92 0.36 0.01 2.50 1.24 5.03 
Occlusion 22 0.73 0.33 0.03 2.04 1.08 3.89 
Female 43 0.68 0.33 0.04 1.98 1.04 3.75 
Laser assistance 49 0.99 
Table 2. Multivariate Cox proportional hazards analysis (best fit) 
Odds 
Factor Coefficient S.D. p ratio 95% CI 
Age (years) 0.065 0.022 0.003 1.07 1.02 1.12 
Occlusion 0.782 0.331 0.018 2.19 1.14 4.18 
Endpoint 
Treatment failure was defined as restenosis of the 
original lesion to greater than 50% diameter stenosis 
or occlusion. Patients were reviewed immediately 
after the procedure, then at 1, 3 and 6 monthly 
intervals. Patients were also assessed noninvasively 
by Duplex scanning and/or  resting ABPI measure- 
ments until failure or termination of the study. In cases 
of failure, further reintervention was determined on 
clinical grounds on an individual patient basis; rest- 
enoses usually being considered for repeat balloon 
angioplasty with or without laser assistance or stent- 
ing while reocclusions were more usually considered 
for bypass. 
Statistical methods 
Data were analysed on a PC. Statistical analysis 
performed using SPIDA (Statistical Package for Inter- 
active Data Analysis, Macquarie University, Sydney, 
Australia). After univariate Cox proportional hazards 
were determined, a multivariate model was devel- 
oped by the stepwise addition of significant variables. 
Survival curves were plotted from data from Kaplan- 
Meier analysis. Fisher's exact test probabilities were 
calculated using a spreadsheet calculator function. 
Results 
Ninety limbs in 82 patients were entered into the trial. 
Forty-four patients were mild claudicants (Fontaine 
Class IIa), 32 severe claudicants (Fontaine IIb) and six 
had either rest pain or tissue loss (Fontaine III or IV). 
The mean ( _+ S.D.) age was 69 ( + 9) years. There were 
22 occlusions and 68 stenoses. 
All five patients with diabetes were randomised to 
receive laser assisted angioplasty (p= 0.04, Fisher's 
exact est). Sixteen of the 22 limbs with occlusion were 
randomised to laser assisted angioplasty (p < 0.05, 
X2= 3.94). There were otherwise no significant differ- 
ences between the two groups. 
Three patients died during follow-up, all with 
treatment success at last follow-up. No death was 
directly or indirectly related to limb ischaemia or the 
intervention. The median duration of follow-up was 
350 days and, for those limbs with treatment success, 
the median follow-up was 430 days. Success ( + S.D.) at 
1 year was 67% (+ 5%), and at 2 years 43% (+ 7%). 
Treatment failed in 40 limbs during follow-up. The 
median time to failure was 220 days. Twenty-one 
limbs underwent repeat intervention comprising four 
thrombectomies (2 early), 11 percutaneous and six 
bypass procedures. 
There was no significant (p > > 0.05) increase in the 
likelihood (Cox proportional hazards) or duration 
(Kaplan-Meier) of success from laser assisted balloon 
angioplasty compared to balloon angioplasty alone. 
The Cox regression found that only increased age, 
female sex, pre-existing occlusion and never having 
smoked were factors positively associated (p < 0.05) 
with treatment failure on univariate analysis (Table 1). 
On multivariate analysis, only age > 75 years and 
initial occlusion were significant factors (Table 2). 
There was no significant difference in success between 
laser and balloon alone within the subgroups of those 
with and without initial occlusion (Fig. 1). 
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Fig. 1. Kaplan-Meier survival curves for limbs treated with laser 
assisted balloon angioplasty ( ) or balloon angioplasty alone 
( - -  -). Figure shows data points for which the standard eviation of 
survival is less than 10%. 
Discussion 
Our early results with laser angioplasty 3'4 were 
encouraging, suggesting that the treatment may be 
able to be extended to a wide range of patients with 
peripheral vascular disease including those who 
would otherwise require bypass urgery. Patients with 
superficial femoral artery occlusions less than 8cm in 
length and with good (2 to 3 vessel) run-off had better 
results than patients with longer length occlusions and 
poor (0 or 1 vessel) run-off. 4 However, with improve- 
ment in guide wire technolog365 the number of 
occluded segments that were able to be crossed 
without use of laser for initial recanalisation i creased 
considerably, so that the main issue which needed to 
be resolved was whether the debulking of atheroma, 
theoretically associated with the use of laser, contrib- 
uted to improved long term patency. 
We chose to study the effect of balloon angioplasty 
with and without laser in the superficial femoral 
segment and, in aiming for as homogeneous a
population of patients as possible, restricted entry into 
the trial to short segment stenoses and occlusions less 
than 3cm with good run-off and with no other 
significant disease in the superficial femoral segment 
or proximally in the iliac segment. We found that the 
number of eligible patients at each of our centres was 
small, as most patients requiring intervention on the 
basis of their clinical symptoms had much more 
extensive disease xcluding them from the trial. 
Our study confirms the findings of others, 7-12 that 
there is no significant benefit from the addition of laser 
to balloon angiplasty. The nature of the lesion (occlu- 
sion vs. stenosis) or patient factors (such as age > 75 
years) appear to be more important in determining the 
outcome of percutaneous intervention. 
Three vessels occluded within 2 days of the proce- 
dure; all had had initial occlusions and had undergone 
laser assisted balloon angioplasb¢. Exclusion in the 
reporting of results of earl~¢ "technical" failures is now 
recommended asinvalid.°However, the difference in 
outcome between standard balloon angioplasty and 
the laser assisted group was unaffected even with 
exclusion of these early failures. 
The use of the "hot tip" laser as an adjunctive 
procedure for uncomplicated angioplasty cannot be 
recommended. It may still have a role, however, for 
attempted recancalisation f short segment occlusions 
which cannot be crossed with a guide wire, although 
this is now only a minority of lesions. 
We were disappointed with the overall success rates 
of 69% at i year and 47% at 2 years for both groups of 
patients considering that these lesions were the most 
favourable that we could find to subject o percuta- 
neous intervention. We would not recommend an 
aggressive approach to minimally symptomatic or 
asymptomatic localised lesions on the basis that this 
might prevent subsequent more extensive occlusion of 
the superficial femoral segment as the long term 
success appears at best only modest for lesions 
otherwise considered to be suited to this form of 
intervention. 
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